| 1 |
Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens |
|
|
| Poulin, E., Greanya, E.D., Partovi, N., Shapiro, R.J., Al-Khatib, M., Ensom, M.H.H. |
|
| Therapeutic Drug Monitoring. 2011; 33(1): 50-55 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Pharmacokinetic drug interaction of mycophenolate with Co-amoxiclav in renal transplant patients |
|
|
| Ratna, P., Mathew, B.S., Annapandian, V.M., Saravanakumar, K., Basu, G., Tamilarasi, V., Fleming, D.H. |
|
| Transplantation. 2011; 91(6): e36-e38 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients |
|
|
| Al-Khatib, M., Shapiro, R.J., Partovi, N., Ting, L.S.L., Levine, M., Ensom, M.H.H. |
|
| Annals of Pharmacotherapy. 2010; 44(1): 19-27 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Mycophenolic acid estimation by pooled sampling: A novel strategy |
|
|
| Mathew, B.S., Fleming, D.H., Prasanna, S., Basu, G., Chandy, S.J., John, G.T. |
|
| Therapeutic Drug Monitoring. 2010; 32(2): 141-144 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period |
|
|
| Mathew, B.S., Fleming, D.H., Annapandian, V.M., Prasanna, S., Prasanna, C.G., Chandy, S.J., John, G.T. |
|
| Therapeutic Drug Monitoring. 2010; 32(2): 136-140 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
A Possible simplification for the estimation of area under the curve (AUC0-12) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus |
|
|
| Fleming, D.H., Mathew, B.S., Prasanna, S., Annapandian, V.M., John, G.T. |
|
| Therapeutic Drug Monitoring. 2010; 33(2): 165-170 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Can mycophenolic acid dose requirement during the first transplant help predict dosing for the second transplant? |
|
|
| Annapandian, V.M., Basu, G., Mathew, B.S., Fleming, D.H., Jacob, C.K., John, G.T. |
|
| Nephrology Dialysis Transplantation. 2010; 25(10): 3449-3452 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients |
|
|
| Barraclough, K.A., Isbel, N.M., Franklin, M.E., Lee, K.J., Taylor, P.J., Campbell, S.B., Petchey, W.G., Staatz, C.E. |
|
| Therapeutic Drug Monitoring. 2010; 32(6): 723-733 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Pharmacokinetic interaction between sodium valproate and mycophenolate in Renal allograft recipients |
|
|
| Annapandian, V.M., John, G.T., Mathew, B.S., Fleming, D.H. |
|
| Transplantation. 2009; 88(9): 1143-1145 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Stability issues of mycophenolic acid in plasma: From patient to laboratory |
|
|
| Mathew, B.S., John, G.T., Chandy, S.J., Fleming, D.H. |
|
| Indian Journal of Pharmaceutical Sciences. 2009; 71(5): 559-561 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Limited sampling strategies for mycophenolic acid in solid organ transplantation: A systematic review |
|
|
| Bruchet, N.K., Ensom, M.H.H. |
|
| Expert Opinion on Drug Metabolism and Toxicology. 2009; 5(9): 1079-1097 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: Assessment of impact of cyclosporine dose in asian renal transplant patients |
|
|
| Yau, W.-P., Vathsala, A., Lou, H.-X., Zhou, S., Chan, E. |
|
| Journal of Clinical Pharmacology. 2009; 49(6): 684-699 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review |
|
|
| Knight SR, Morris PJ |
|
| TRANSPLANTATION. 2008; 85(12): 1675-1685 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Comparison between a pooled and measured 6hr area under the curve for mycophenolic acid |
|
|
| Mathew BS, Fleming DH, Jeyaseelan V, et al. |
|
| THERAPEUTIC DRUG MONITORING. 2007; 29 (4): 549-549 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
On the road towards strategic application of therapeutic drug monitoring of mycophenolic acid in renal allograft recipients |
|
|
| Kuypers, D.R. |
|
| Journal of Postgraduate Medicine. 2006; 52(4): 243 |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid |
|
|
| Van Hest, R.M. |
|
| Journal of Postgraduate Medicine. 2006; 52(4): 244 |
|
| [Pubmed] [Google Scholar] |
|
